omega-n-methylarginine has been researched along with Brain Vascular Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karlsson, WK; Kruuse, C; Sørensen, CG | 1 |
| Higashino, H; Lambev, I; Simeonova, K; Suzuki, A | 1 |
| Mayhan, WG | 1 |
1 review(s) available for omega-n-methylarginine and Brain Vascular Disorders
| Article | Year |
|---|---|
l-arginine and l-NMMA for assessing cerebral endothelial dysfunction in ischaemic cerebrovascular disease: A systematic review.
Topics: Arginine; CADASIL; Cerebrovascular Disorders; Clinical Trials as Topic; Endothelium, Vascular; Humans; omega-N-Methylarginine; Vasodilation | 2017 |
2 other study(ies) available for omega-n-methylarginine and Brain Vascular Disorders
| Article | Year |
|---|---|
Haemodynamic effects of NO-synthase inhibitors, NG-monomethyl-L-arginine, NG-nitro-L-arginine and NG-nitro-L-arginine methyl ester, and NO-donor, glyceryl trinitrate, in conscious SHRSP and WKY.
Topics: Animals; Blood Pressure; Cerebrovascular Disorders; Enzyme Inhibitors; Heart Rate; Hemodynamics; Hypertension; Microspheres; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroarginine; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regional Blood Flow; Vasodilator Agents | 1995 |
Constrictor responses of the rat basilar artery during diabetes mellitus.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arginine Vasopressin; Basilar Artery; Blood Pressure; Cerebrovascular Disorders; Diabetes Mellitus, Experimental; Endothelin-1; Enzyme Inhibitors; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Thromboxanes; Vasoconstriction; Vasoconstrictor Agents | 1998 |